| COCP Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the COCP shares outstanding history going back to 1/24/2018:
Also see: COCP Market Cap History COCP YTD Return |
COCP Shares Outstanding History — Cocrystal Pharma Share Count Over Time
As of 3/24/2026 Cocrystal Pharma has 13.79 million COCP shares outstanding. Investors often track the COCP shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows COCP share count trends over time, with 36 historical shares outstanding datapoints presented, dating back to 1/24/2018.
| COCP Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
COCP Historical Shares Outstanding: +26.50% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COCP Stock Price Chart |
| About Cocrystal Pharma Inc |
| Cocrystal Pharma, Inc. is a clinical-stage biotechnology company. Co. is engaged in discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses (HCV). It is developing small molecule antiviral therapeutics that inhibit the essential viral replication function of RNA viruses causing acute and chronic viral diseases. It has several candidates under development for the treatment of influenza infection. CC-42344 is a novel PB2 inhibitor, which is a preclinical lead for the treatment of pandemic and seasonal influenza A. We show 36 historical shares outstanding datapoints in our coverage of COCP's shares outstanding history. Understanding the changing numbers of COCP shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like COCP versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching COCP by allowing them to research COCP shares outstanding history as well as any other stock in our coverage universe. |
| COCP Current Stock Quote |
Quotes delayed 20 minutes  Free COCP Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| COCP Share Performance |
| Shares Outstanding Peers |
| Cocrystal Pharma (COCP) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CODX Shares Outstanding History COGT Shares Outstanding History COLL Shares Outstanding History COM Shares Outstanding History CON Shares Outstanding History COO Shares Outstanding History COOL Shares Outstanding History COR Shares Outstanding History CORI Shares Outstanding History CORT Shares Outstanding History More Healthcare companies » |
COCP Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
